Overview
Sickle Cell Crisis
Quick Reference
Critical Alerts
- Acute Chest Syndrome (ACS) is life-threatening: New infiltrate + respiratory symptoms
- Fever in SCD = Medical emergency: Functional asplenia → overwhelming sepsis
- Opioids are appropriate for pain crisis: Do not undertreat pain
- Exchange transfusion for severe ACS, stroke, multi-organ failure: Simple transfusion may not be enough
- Think stroke in any neurological change: Low threshold for imaging
- Splenic sequestration can cause rapid death: Especially in children
Key Diagnostics
| Test | Finding | Significance |
|---|---|---|
| CBC | Low Hgb, elevated reticulocytes | Baseline hemolysis |
| Reticulocyte count | May be low (aplastic crisis) or high | Erythropoiesis status |
| CXR | New infiltrate | Acute chest syndrome |
| Type and screen | Blood availability | Transfusion preparation |
| Pulse oximetry | Hypoxia | ACS or PE |
| Blood cultures | If febrile | Rule out sepsis |
Emergency Treatments
| Condition | Treatment | Details |
|---|---|---|
| Pain crisis | IV opioids (morphine, hydromorphone) | Titrate to pain relief |
| ACS | O2, antibiotics, transfusion, bronchodilators | ICU if severe |
| Fever (>8.5°C) | Empiric antibiotics | Ceftriaxone + cover atypicals |
| Stroke | Exchange transfusion | Target HbS <30% |
| Aplastic crisis | Transfusion | Correct anemia |
| Splenic sequestration | Transfusion | Urgent volume/RBC replacement |
Definition
Overview
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a single nucleotide mutation resulting in abnormal hemoglobin (HbS) that polymerizes under low oxygen conditions, causing red blood cells to become rigid and sickle-shaped. This leads to vaso-occlusion, hemolysis, and progressive organ damage. Sickle cell crisis refers to acute complications requiring emergency care.
Types of Crises
| Type | Mechanism | Key Features |
|---|---|---|
| Vaso-occlusive (Pain) Crisis | Microvascular occlusion | Most common; bone, chest, abdomen pain |
| Acute Chest Syndrome | Pulmonary vaso-occlusion ± infection | Fever, new infiltrate, respiratory symptoms |
| Aplastic Crisis | Parvovirus B19 → marrow suppression | Severe anemia, low reticulocytes |
| Splenic Sequestration | Blood pooling in spleen | Rapid anemia, splenomegaly, shock |
| Hemolytic Crisis | Accelerated hemolysis | Worsening anemia, high LDH/bilirubin |
| Stroke | Cerebral vaso-occlusion or hemorrhage | Focal deficits, altered consciousness |
| Priapism | Penile vascular occlusion | Painful sustained erection > hours |
Epidemiology
- SCD prevalence: 100,000+ in US; 1 in 365 African American births
- Life expectancy: 40-60 years (improved with modern care)
- ED visits: SCD patients have high ED utilization
- ACS is leading cause of death: And second most common cause of hospitalization
- Stroke incidence: 11% by age 20 (without prevention)
Genotypes
| Genotype | Description | Severity |
|---|---|---|
| HbSS | Homozygous (Sickle Cell Anemia) | Most severe |
| HbSC | Compound heterozygous (S + C) | Moderate severity |
| HbS-β0 thalassemia | S + β0 thal | Severe |
| HbS-β+ thalassemia | S + β+ thal | Variable |
| HbAS | Sickle cell trait | Usually asymptomatic |
Pathophysiology
Mechanism of Sickling
- Deoxygenation: Low O2 tension triggers HbS polymerization
- Polymer formation: HbS molecules aggregate into rigid polymers
- Cell deformation: RBCs become rigid, sickle-shaped
- Vaso-occlusion: Sickled cells obstruct microvasculature
- Ischemia-reperfusion injury: Tissue damage, inflammation
- Chronic hemolysis: RBC destruction → anemia
Triggers for Sickling
| Category | Triggers |
|---|---|
| Hypoxia | Altitude, pneumonia, sleep apnea |
| Dehydration | Volume depletion |
| Acidosis | Infection, DKA |
| Cold | Vasoconstriction |
| Stress | Surgery, trauma, psychological |
| Infection | Most common trigger |
Acute Chest Syndrome Pathophysiology
- Pulmonary vaso-occlusion
- Fat embolism from bone marrow infarction
- Infection (bacterial, viral, atypical)
- V/Q mismatch, hypoxemia, further sickling
- Can rapidly progress to respiratory failure
Chronic Organ Damage
| Organ | Manifestation |
|---|---|
| Spleen | Autosplenectomy (functional asplenia) |
| Brain | Stroke, silent infarcts, cognitive impairment |
| Kidneys | Chronic kidney disease, papillary necrosis |
| Heart | Pulmonary hypertension, cardiomyopathy |
| Bones | Avascular necrosis, osteomyelitis |
| Eyes | Proliferative retinopathy |
| Liver | Iron overload, intrahepatic cholestasis |
Clinical Presentation
Vaso-Occlusive (Pain) Crisis
Typical Presentation:
Physical Examination:
Acute Chest Syndrome
Diagnostic Criteria:
Symptoms:
Stroke
Presentation:
Other Presentations in SCD
| Condition | Clues |
|---|---|
| Fever (>8.5°C) | Medical emergency—functional asplenia |
| Priapism | Painful erection > hours |
| Splenic sequestration | LUQ fullness, falling Hgb, hypovolemia |
| Aplastic crisis | Severe anemia, low reticulocytes, parvovirus contact |
| Bone infarction vs osteomyelitis | Distinguish: Osteomyelitis has focal warmth, MRI helps |
History
Key Questions:
Severe pain in bones (back, long bones, ribs), abdomen, chest
Common presentation.
Sudden onset, often with identifiable trigger
Common presentation.
May last hours to days
Common presentation.
Often similar pattern to prior crises
Common presentation.
Red Flags
Life-Threatening Complications
| Finding | Concern | Action |
|---|---|---|
| New pulmonary infiltrate + respiratory symptoms | Acute Chest Syndrome | O2, transfusion, antibiotics, ICU |
| Fever >8.5°C | Sepsis in asplenic patient | Blood cultures, empiric antibiotics |
| Neurological deficit | Stroke | Emergent imaging, exchange transfusion |
| Rapid drop in Hgb + splenomegaly | Splenic sequestration | Urgent transfusion |
| Hgb drop + low reticulocytes | Aplastic crisis | Transfusion |
| Priapism > hours | Ischemic priapism | Urology, aspiration, phenylephrine |
| Multi-organ failure | Severe crisis | Exchange transfusion, ICU |
Differential Diagnosis
Pain Crisis Mimics
| Diagnosis | Features |
|---|---|
| Osteomyelitis | Fever, focal warmth; Salmonella common in SCD |
| Avascular necrosis | Chronic hip/shoulder pain |
| Cholecystitis | RUQ pain, pigment gallstones common |
| Appendicitis | RLQ pain, anorexia |
| Pulmonary embolism | Dyspnea, pleuritic chest pain |
| Myocardial infarction | Chest pain, ECG changes |
| Pneumonia | Cough, fever, infiltrate |
Acute Chest Syndrome vs Pneumonia vs PE
- Often cannot distinguish clinically
- Treat empirically for all
- ACS may evolve from pain crisis
Diagnostic Approach
Laboratory Studies
| Test | Purpose | Expected Finding |
|---|---|---|
| CBC | Anemia, WBC | Baseline Hgb usually 6-9 g/dL (SS) |
| Reticulocyte count | Marrow response | Elevated (hemolytic); low (aplastic crisis) |
| Type and screen | Transfusion prep | Extended phenotype matching |
| Blood cultures | If febrile | Rule out bacteremia |
| BMP | Renal function | May have baseline CKD |
| LFTs, bilirubin | Hemolysis, liver involvement | Elevated indirect bilirubin |
| LDH | Hemolysis marker | Elevated at baseline |
| Urinalysis | UTI, hemoglobinuria | Hematuria may be chronic |
| ABG | Hypoxemia, acidosis | If respiratory distress |
| HbS percentage | For transfusion target | Usually by Hgb electrophoresis |
Imaging
| Study | Indication |
|---|---|
| CXR | Fever, respiratory symptoms (ACS) |
| CT Head | Neurological deficit (stroke) |
| MRI Brain | If CT negative but clinical concern |
| CT Angio Chest | PE if suspected (distinguish from ACS) |
| Abdominal imaging | If concern for cholecystitis, splenic sequestration |
Special Considerations
- Know patient's baseline Hgb
- Extended RBC phenotype matching (reduces alloimmunization)
- Higher incidence of iron overload (if chronically transfused)
Treatment
Principles of Management
- Treat pain aggressively: Opioids are appropriate
- Hydration: IV fluids (avoid overload)
- Oxygen: Only if hypoxic (avoid hyperoxia)
- Identify and treat triggers: Infection, dehydration
- Transfusion: Based on indication
- Early recognize ACS and stroke: Life-threatening
Pain Crisis Management
Analgesia:
| Drug | Dose | Notes |
|---|---|---|
| Morphine | 0.1-0.15 mg/kg IV q2-3h | Standard opioid |
| Hydromorphone | 0.015-0.02 mg/kg IV q2-3h | Alternative |
| Ketorolac | 15-30 mg IV × 5 days max | Adjunctive (caution renal) |
| Acetaminophen | 1g PO/IV q6h | Opioid-sparing |
Pain Assessment:
- Treat to patient's reported pain level
- Use patient's known effective regimen
- PCA may be needed for severe pain
- Reassess frequently
Supportive Care:
| Measure | Details |
|---|---|
| IV Fluids | NS or D5-1/2NS at 1-1.5× maintenance; avoid overhydration |
| Incentive spirometry | Prevent atelectasis and ACS (q2h while awake) |
| Warming | Avoid cold |
| DVT prophylaxis | If hospitalized |
| Monitoring | Vitals, SpO2, pain score |
Acute Chest Syndrome
Treatment Steps:
| Intervention | Details |
|---|---|
| Oxygen | Maintain SpO2 ≥95% |
| Analgesia | Continue pain management |
| Antibiotics | Ceftriaxone + azithromycin/fluoroquinolone (cover atypicals) |
| Bronchodilators | If wheezing |
| Simple transfusion | If Hgb drop or moderate symptoms |
| Exchange transfusion | If severe (PaO2 <60 on room air, deteriorating, multi-lobar) |
| ICU admission | If severe, worsening, or on high O2 |
Transfusion Targets:
- Simple transfusion: Raise Hgb to 10 g/dL (not higher—hyperviscosity)
- Exchange transfusion: Target HbS <30%
Fever/Sepsis
All febrile SCD patients:
- Blood cultures
- Empiric antibiotics ASAP (ceftriaxone 2g IV)
- Cover encapsulated organisms (Strep pneumo, H. flu, Salmonella)
- Low threshold for admission
Stroke
Treatment:
| Intervention | Details |
|---|---|
| Emergent exchange transfusion | Target HbS <30%, Hgb ~10 |
| Supportive care | O2, IV fluids, monitoring |
| Avoid thrombolytics | Limited data; generally not used |
| Neurology consultation | Immediate |
| MRI/MRA | Assess extent, vascular involvement |
Priapism
Ischemic Priapism (>4 hours):
| Step | Details |
|---|---|
| Analgesia | Pain control |
| Aspiration | By urology; aspirate corpora cavernosa |
| Injection | Phenylephrine (dilute) into corpora |
| If refractory | Surgical shunt |
| Exchange transfusion | If not responding |
Splenic Sequestration
Treatment:
- Emergent transfusion (may need large volumes)
- Fluid resuscitation
- ICU admission if hemodynamically unstable
- Splenectomy after stabilization (if recurrent)
Aplastic Crisis
Treatment:
- Transfusion to correct anemia
- Usually self-limited (parvovirus B19)
- Isolation (contagious to others, especially pregnant women)
- Monitor for recovery (reticulocyte count)
Disposition
ICU Admission
- Severe ACS (high O2 requirement, worsening)
- Stroke
- Multi-organ failure
- Hemodynamic instability (sepsis, splenic sequestration)
- Exchange transfusion in progress
Floor Admission
- Pain crisis requiring IV opioids
- Mild/moderate ACS
- Fever requiring IV antibiotics
- Aplastic crisis needing transfusion
Discharge Criteria
- Pain controlled on oral medications
- Afebrile
- Adequate oxygenation
- Able to maintain hydration
- Close follow-up arranged
Follow-Up
| Situation | Follow-Up |
|---|---|
| Pain crisis | Hematology within 1-2 weeks |
| ACS (mild, discharged) | Hematology within 1 week |
| Post-transfusion | Hematology 1-2 weeks (HbS level) |
| Stroke | Neurology, chronic transfusion program |
Patient Education
Condition Explanation
- "Sickle cell disease causes your red blood cells to become stiff and sticky, which can block blood flow and cause pain."
- "We are giving you strong pain medicine and fluids to help with this crisis."
- "It's important to recognize the signs of serious complications like chest problems or fever."
Prevention
- Stay hydrated
- Avoid extreme temperatures, high altitude
- Manage stress
- Take hydroxyurea as prescribed
- Get vaccinations (pneumococcal, meningococcal, flu)
- Prompt medical attention for fever
Warning Signs
- Fever (>38.5°C)
- Chest pain, difficulty breathing
- Severe headache, vision changes, weakness/numbness
- Abdominal swelling
- Priapism (erection >4 hours)
Special Populations
Pregnancy
- High-risk pregnancy
- Increased frequency of crises
- Risk of preterm labor, IUGR
- Hydroxyurea contraindicated
- May need prophylactic transfusions
- Obstetrics and hematology co-management
Pediatric
- Higher risk of splenic sequestration
- Stroke prevention (transcranial Doppler screening)
- Penicillin prophylaxis until age 5
- Spleen may be palpable (before autoinfarction)
Surgical Patients
- Preoperative transfusion to Hgb ~10
- Aggressive hydration, oxygenation, warming
- Pain management planning
Sickle Cell Trait (HbAS)
- Usually asymptomatic
- Rare complications: Splenic infarct at altitude, hematuria
- Do not treat like SCD
Quality Metrics
Performance Indicators
| Metric | Target | Rationale |
|---|---|---|
| Time to first dose of analgesia | <30 minutes | Treat pain rapidly |
| Blood cultures before antibiotics (if febrile) | 100% | Adequate workup |
| Incentive spirometry documented | 100% of admitted | Prevent ACS |
| Transfusion with extended phenotype matching | 100% | Prevent alloimmunization |
| Hematology follow-up arranged | 100% | Ongoing care |
Documentation Requirements
- Pain score and treatment response
- Baseline hemoglobin
- Prior complications (ACS, stroke)
- Opioid history and regimen
- Transfusion history
- HbS level (if available)
Key Clinical Pearls
Diagnostic Pearls
- Pain crisis is a diagnosis of exclusion: Rule out infection, ACS, etc.
- ACS may evolve from pain crisis: Repeat CXR if worsening
- Fever = emergency in SCD: Functional asplenia
- Low reticulocytes with anemia = aplastic crisis: Think parvovirus
- Know the patient's baseline Hgb: Drop of >1-2 g/dL is significant
- Stroke can be subtle: Any neuro change warrants imaging
Treatment Pearls
- Do not undertreat pain: Opioids are appropriate
- Transfuse to Hgb ~10, not higher: Hyperviscosity risk
- Exchange transfusion for severe ACS/stroke: Target HbS <30%
- Incentive spirometry prevents ACS: 10 breaths q2h
- Cover atypical organisms in ACS: Chlamydia, Mycoplasma
- Don't give supplemental O2 unless hypoxic: May suppress erythropoiesis
Disposition Pearls
- Most pain crises need admission: Unless rapid resolution
- Low threshold for ICU with ACS: Can deteriorate quickly
- Stroke requires immediate hematology and exchange: Do not delay
- Ensure sickle cell follow-up: Chronic disease management reduces crises
References
- Yawn BP, et al. Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members. JAMA. 2014;312(10):1033-1048.
- Howard J, et al. Guideline on the management of acute chest syndrome in sickle cell disease. Br J Haematol. 2015;169(4):492-505.
- Rees DC, et al. Sickle-cell disease. Lancet. 2010;376(9757):2018-2031.
- DeBaun MR, et al. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease. Blood Adv. 2020;4(8):1554-1588.
- Chou ST, et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv. 2020;4(2):327-355.
- Glassberg J. Evidence-based management of sickle cell disease in the emergency department. Emerg Med Pract. 2011;13(8):1-20.
- Brandow AM, DeBaun MR. Key Components of Pain Management for Children and Adults with Sickle Cell Disease. Hematol Oncol Clin North Am. 2018;32(3):535-550.
- UpToDate. Acute vaso-occlusive pain management in sickle cell disease. 2024.